Trofinetide Completed Phase 2 Trials for Rett's Syndrome Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02715115A Safety Study of NNZ-2566 in Pediatric Rett Syndrome
NCT01703533A Safety Study of NNZ-2566 in Patients With Rett Syndrome